| abstract |
The present invention relates to aviramycin derivatives, methods for their production using genetic engineering, biosynthesis, medicaments containing said compounds, and the use of said compounds in the manufacture of medicaments against infectious diseases. The present invention also relates to nucleic acids, proteins and gene clusters involved in the production of the above aviramycin derivatives, and corresponding cells. |